
Semaglutide (1 mg)
Once weekly - It has to be administered on the same day each week, any time of day, with or without food.
Inject Wegovy under the skin in your stomach area, thigh or upper arm once a week using an injection pen.
Don’t worry, it’s actually much easier than it sounds and we’ll provide you with full instructions on how to use it.
You must follow a strict dosage as advised by your healthcare provider.
It is a prescription semaglutide injection used once weekly as part of a clinician-guided weight management plan for eligible patients. The 1 mg strength is an intermediate step in the gradual injectable dosing schedule.
No. Injectable treatment generally begins at 0.25 mg once weekly for weeks 1–4, followed by 0.5 mg during weeks 5–8. The 1 mg stage normally follows during weeks 9–12.
It is administered once weekly, preferably on the same day every week. It can be taken at any time of day and with or without food.
Inject it under the skin of the abdomen, thigh, or upper arm. Rotate the injection site and follow the instructions supplied with your prescribed injection device.
Under the standard escalation schedule, the next strength is generally 1.7 mg once weekly during weeks 13–16, provided the current dose is tolerated.
Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, tiredness, bloating, belching, dizziness, and heartburn. Speak with your healthcare professional if symptoms are severe or persistent.
Contact your healthcare professional rather than changing the dose yourself. During dose escalation, the prescribing information says that escalation may be delayed for 4 weeks when a dose is not tolerated.
Yes. It is a prescription medicine and should be used only after a healthcare professional determines that treatment is appropriate and provides the correct dosing schedule.
Follow the instructions provided with your medicine and contact your healthcare professional if you are unsure how to resume treatment, especially if you have missed more than one dose.
Store the injection according to the instructions on the package and keep it protected from inappropriate heat or freezing. Always follow the storage guidance supplied with your specific pen.
The 1 mg strength is normally the third stage in the injectable semaglutide dose-escalation schedule. After completing four weeks at 0.25 mg and four weeks at 0.5 mg, eligible patients generally progress to 1 mg once weekly during weeks 9 through 12 if earlier doses have been tolerated. The injection may be administered under the skin of the abdomen, thigh, or upper arm and can be taken at any time of day, with or without meals, preferably on the same day each week. Rotate injection sites and follow the instructions provided with your prescribed device. Common gastrointestinal side effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. If the current strength is not well tolerated, the prescribing information allows clinicians to consider delaying further dose escalation. Never increase the dose independently.